Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.12 USD | +3.47% | +7.44% | -20.94% |
Apr. 22 | Trupanion Introduces truInsights: A Pet Health Data Initiative | CI |
Apr. 05 | Piper Sandler Cuts Price Target on Trupanion to $28 From $32, Maintains Overweight Rating | MT |
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.94% | 1.01B | C | ||
+13.21% | 9.63B | B- | ||
+16.74% | 6.08B | C | ||
+91.91% | 4.16B | - | ||
-1.08% | 2.31B | B+ | ||
+2.18% | 862M | - | D+ | |
+85.42% | 748M | - | C | |
+7.80% | 162M | - | - | |
-8.15% | 68.79M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TRUP Stock
- Ratings Trupanion, Inc.